1. Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo
- Author
-
Paul Verlé, Philippe Büscher, Epco Hasker, Delphin Mavinga Phanzu, Marleen Boelaert, Oscar N’lemvo Kiabanzawoko, Anja De Weggheleire, Raquel Inocêncio da Luz, and Eric Miaka
- Subjects
Male ,Veterinary medicine ,Physiology ,Epidemiology ,RC955-962 ,Pathology and Laboratory Medicine ,Serology ,Medical Conditions ,Filter Paper ,Zoonoses ,Arctic medicine. Tropical medicine ,Medicine and Health Sciences ,Ethnicities ,Medicine ,African trypanosomiasis ,Enzyme-Linked Immunoassays ,Child ,Protozoans ,Aged, 80 and over ,Eukaryota ,Middle Aged ,Trypanocidal Agents ,Body Fluids ,Dried blood spot ,Laboratory Equipment ,Blood ,Infectious Diseases ,Child, Preschool ,Population Surveillance ,Democratic Republic of the Congo ,Engineering and Technology ,Female ,Anatomy ,Public aspects of medicine ,RA1-1270 ,Research Article ,Neglected Tropical Diseases ,Adult ,Trypanosoma ,Adolescent ,Screening test ,Equipment ,Kongo People ,Research and Analysis Methods ,African Trypanosomiasis ,Young Adult ,Trypanosomiasis ,Parasitic Diseases ,Humans ,Serologic Tests ,Disease Eradication ,Immunoassays ,Aged ,African People ,Protozoan Infections ,business.industry ,Organisms ,Public Health, Environmental and Occupational Health ,Biology and Life Sciences ,Infant ,Reproducibility of Results ,Tropical Diseases ,medicine.disease ,Parasitic Protozoans ,Cross-Sectional Studies ,Trypanosomiasis, African ,Medical Risk Factors ,People and Places ,Immunologic Techniques ,Feasibility Studies ,Population Groupings ,Dried Blood Spot Testing ,business - Abstract
In recent years, the number of reported Human African Trypanosomiasis (HAT) cases caused by Trypanosoma brucei (T.b.) gambiense has been markedly declining, and the goal of ‘elimination as a public health problem’ is within reach. For the next stage, i.e. interruption of HAT transmission by 2030, intensive screening and surveillance will need to be maintained, but with tools and strategies more efficiently tailored to the very low prevalence. We assessed the sequential use of ELISA and Immune Trypanolysis (ITL) on dried blood spot (DBS) samples as an alternative to the traditional HAT field testing and confirmation approach. A cross-sectional study was conducted in HAT endemic and previously endemic zones in Kongo Central province, and a non-endemic zone in Haut Katanga province in the Democratic Republic of the Congo (DRC). Door-to-door visits were performed to collect dried blood spot (DBS) samples on filter paper. ELISA/T.b. gambiense was conducted followed by ITL for those testing positive by ELISA and in a subset of ELISA negatives. In total, 11,642 participants were enrolled. Of these, 11,535 DBS were collected and stored in appropriate condition for ELISA testing. Ninety-seven DBS samples tested positive on ELISA. In the endemic zone, ELISA positivity was 1.34% (95%CI: 1.04–1.64). In the previously endemic zone and non-endemic zone, ELISA positivity was 0.34% (95% CI: 0.13–0.55) and 0.37% (95% CI: 0.15–0.60) respectively. Among the ELISA positives, only two samples had a positive ITL result, both from the endemic zone. One of those was from a former HAT patient treated in 2008 and the other from an individual who unfortunately had deceased prior to the follow-up visit. Our study showed that a surveillance strategy, based on DBS samples and centralized testing with retracing of patients if needed, is feasible in DRC. ELISA seems well suited as initial test with a similar positivity rate as traditional screening tests, but ITL remains complex. Alternatives for the latter, also analyzable on DBS, should be further explored., Author summary Human African Trypanosomiasis (HAT), also known as sleeping sickness is a parasitic disease, transmitted by tsetse flies, that is usually fatal if untreated. The number of cases have been rapidly declining over the past years indicating that elimination of the disease as a public health problem is within reach. To achieve the next stage, i.e. interruption of HAT transmission by 2030, intensive screening and surveillance will need to be maintained, but with tools and strategies more efficiently tailored to the very low prevalence. In contrast to the traditional approach of sending laboratory expertise to the field, we assessed an alternative approach based on the collection of dried blood samples on filter paper that were tested in a regional laboratory. Samples were taken in endemic, previously endemic and non-endemic villages and tested by ELISA and Immune Trypanolysis. The ELISA positivity rates were similar to those of other screening techniques currently used and Immune Trypanolysis was highly specific. Hence for surveillance in HAT endemic areas, collecting dried blood samples followed by centralized testing could become an alternative to the current strategy of active screening by mobile teams with on the spot confirmation. It has also potential for post-elimination surveillance to monitor resurgence and for exploratory surveillance in historic foci. Though highly specific, Immune Trypanolysis remains too complex for use in intermediate level laboratories, to further expand this strategy an alternative second step test is required.
- Published
- 2021